254 related articles for article (PubMed ID: 17241597)
1. Susceptibility of Staphylococcus aureus to fusidic acid: Canadian data.
Rennie RP
J Cutan Med Surg; 2006; 10(6):277-80. PubMed ID: 17241597
[TBL] [Abstract][Full Text] [Related]
2. Dissemination of fusidic acid resistance among Staphylococcus aureus clinical isolates.
Yu F; Liu Y; Lu C; Lv J; Qi X; Ding Y; Li D; Huang X; Hu L; Wang L
BMC Microbiol; 2015 Oct; 15():210. PubMed ID: 26463589
[TBL] [Abstract][Full Text] [Related]
3. Oral fusidic acid fails to eradicate methicillin-resistant Staphylococcus aureus colonization and results in emergence of fusidic acid-resistant strains.
Chang SC; Hsieh SM; Chen ML; Sheng WH; Chen YC
Diagn Microbiol Infect Dis; 2000 Feb; 36(2):131-6. PubMed ID: 10705056
[TBL] [Abstract][Full Text] [Related]
4. In vitro antimicrobial findings for fusidic acid tested against contemporary (2008-2009) gram-positive organisms collected in the United States.
Jones RN; Mendes RE; Sader HS; Castanheira M
Clin Infect Dis; 2011 Jun; 52 Suppl 7():S477-86. PubMed ID: 21546624
[TBL] [Abstract][Full Text] [Related]
5. High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus: a cautionary tale.
Williamson DA; Monecke S; Heffernan H; Ritchie SR; Roberts SA; Upton A; Thomas MG; Fraser JD
Clin Infect Dis; 2014 Nov; 59(10):1451-4. PubMed ID: 25139961
[TBL] [Abstract][Full Text] [Related]
6. The independent evolution of resistance to ciprofloxacin, rifampicin, and fusidic acid in methicillin-resistant Staphylococcus aureus in Australian teaching hospitals (1990-1995). Australian Group for Antimicrobial Resistance (AGAR).
Gottlieb T; Mitchell D
J Antimicrob Chemother; 1998 Jul; 42(1):67-73. PubMed ID: 9700530
[TBL] [Abstract][Full Text] [Related]
7. Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus.
Howden BP; Grayson ML
Clin Infect Dis; 2006 Feb; 42(3):394-400. PubMed ID: 16392088
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the activity of fusidic acid tested against contemporary Gram-positive clinical isolates from the USA and Canada.
Pfaller MA; Castanheira M; Sader HS; Jones RN
Int J Antimicrob Agents; 2010 Mar; 35(3):282-7. PubMed ID: 20036520
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of Staphylococcus aureus and coagulase-negative Staphylococcus strains to fusidic acid.
Tünger O; Arisoy A; Kurutepe S; Akçali S; Ozbakkaloğlu B
Int J Antimicrob Agents; 2001 Nov; 18(5):445-7. PubMed ID: 11711260
[No Abstract] [Full Text] [Related]
10. Mutations in rpoB and fusA cause resistance to rifampicin and fusidic acid in methicillin-resistant Staphylococcus aureus strains from a tertiary hospital in Malaysia.
Lim KT; Teh CS; Yusof MY; Thong KL
Trans R Soc Trop Med Hyg; 2014 Feb; 108(2):112-8. PubMed ID: 24336696
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility to and resistance determinants of fusidic acid in Staphylococcus aureus isolated from Chinese children with skin and soft tissue infections.
Liu Y; Geng W; Yang Y; Wang C; Zheng Y; Shang Y; Wu D; Li X; Wang L; Yu S; Yao K; Shen X
FEMS Immunol Med Microbiol; 2012 Mar; 64(2):212-8. PubMed ID: 22066960
[TBL] [Abstract][Full Text] [Related]
12. [Predominance of multidrug resistant strains with reduced susceptibility to fusidic acid among methicillin-resistant Staphylococcus aureus strains (MRSA) isolated in the Gdánsk region].
Wiśniewska K; Piechowicz L; Galiński J
Pol Merkur Lekarski; 2000 Nov; 9(53):746-50. PubMed ID: 11204320
[TBL] [Abstract][Full Text] [Related]
13. Fusidic acid resistance in Staphylococcus aureus isolates.
Brown EM; Thomas P
Lancet; 2002 Mar; 359(9308):803. PubMed ID: 11888633
[No Abstract] [Full Text] [Related]
14. Fusidic acid resistance in Staphylococcus aureus nasal carriage strains in nine European countries.
den Heijer CD; van Bijnen EM; Paget WJ; Stobberingh EE
Future Microbiol; 2014; 9(6):737-45. PubMed ID: 25046521
[TBL] [Abstract][Full Text] [Related]
15. [In vitro sensitivity of methicillin-resistant Staphylococcus aureus to fusidic acid and trimethoprim-sulfamethoxazole].
Memikoğlu KO; Bayar B; Kurt O; Cokça F
Mikrobiyol Bul; 2002 Apr; 36(2):141-5. PubMed ID: 12652865
[TBL] [Abstract][Full Text] [Related]
16. Molecular fingerprinting of fusidic acid- and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals.
Norazah A; Lim VKE; Koh YT; Rohani MY; Zuridah H; Spencer K; Ng PP; Kamel AGM
J Med Microbiol; 2002 Dec; 51(12):1113-1116. PubMed ID: 12466411
[TBL] [Abstract][Full Text] [Related]
17. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.
Simor AE; Stuart TL; Louie L; Watt C; Ofner-Agostini M; Gravel D; Mulvey M; Loeb M; McGeer A; Bryce E; Matlow A;
Antimicrob Agents Chemother; 2007 Nov; 51(11):3880-6. PubMed ID: 17724154
[TBL] [Abstract][Full Text] [Related]
18. In vitro activities of 18 antimicrobial agents against Staphylococcus aureus isolates from the Institut Pasteur of Madagascar.
Randrianirina F; Soares JL; Ratsima E; Carod JF; Combe P; Grosjean P; Richard V; Talarmin A
Ann Clin Microbiol Antimicrob; 2007 May; 6():5. PubMed ID: 17521424
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of two old antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus.
Yu XH; Song XJ; Cai Y; Liang BB; Lin DF; Wang R
J Antibiot (Tokyo); 2010 Nov; 63(11):657-9. PubMed ID: 20877368
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of retapamulin against Staphylococcus aureus isolates resistant to fusidic acid and mupirocin.
Woodford N; Afzal-Shah M; Warner M; Livermore DM
J Antimicrob Chemother; 2008 Oct; 62(4):766-8. PubMed ID: 18567573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]